NAV
₹17.5530
as of 30 Sept 2026
Expense Ratio
1.04%
Lumpsum returns (CAGR)
- 1Y
- +29.80%
- 3Y
- —
- 5Y
- —
- Since Inception
- +22.22%
SIP returns (XIRR)
- 1Y
- +35.37%
- 3Y
- —
- 5Y
- —
- Since Inception
- +20.79%
Returns calculated from 20 November 2023 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals and Biotechnology70.32%
- Healthcare Services27.68%
- Chemicals and Petrochemicals1.49%
- Healthcare Equipment and Supplies0.17%
Each sector links to the mutual funds most exposed to it.
Thinking about Kotak Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Kotak Healthcare Fund - Regular Plan - Growth Option
- 1Sun Pharmaceutical Industries Ltd.13.96%
- 2Divis Laboratories Ltd.9.25%
- 3Torrent Pharmaceuticals Ltd.4.75%
- 4Molbio Diagnostics Limited4.53%
- 5Max Healthcare Institute Ltd.4.34%
- 6Ami Organics Ltd3.91%
- 7Cipla Ltd.3.67%
- 8Park Medi World Limited (Park Hospital)3.36%
- 9Yatharth Hospital And Trauma Care Services Ltd3.25%
- 10Apollo Hospitals Enterprise Ltd.3.25%
What this fund does
Kotak Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Kotak Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Kotak Mahindra Mutual Fund. The fund has been operational for over 2 years. The current expense ratio is 1.04%.